Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Hybridon advances antisense drug to phase II

Oct. 14, 1998

Aphton initiates phase I/II trial of Gonadimmune in prostate cancer patients

Oct. 14, 1998

Disappointing results of pilot study of SDZ-PSC-833 + doxorubicin in colorectal cancer

Oct. 14, 1998

DepoTech and Chiron submit NDA for DepoCyt

Oct. 13, 1998

Matrix reports promising phase III results for IntraDose in breast cancer

Oct. 13, 1998

NCIC-CTG leads major international trial for new ovarian cancer compound

Oct. 13, 1998

Promising preclinical findings reported for PI-88; phase I testing begins next month

Oct. 13, 1998

Gene therapy targeting Tie2 receptor tyrosine kinase evaluated as antiangiogenic strategy

Oct. 13, 1998

Inex demonstrates effectiveness of new antisense drug

Oct. 13, 1998

New Zeneca facility to manufacture new cancer treatment

Oct. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...